A Phase IV Study of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver

PHASE4CompletedINTERVENTIONAL

Enrollment

2,007

Participants

Timeline

Start Date

May 13, 2020

Primary Completion Date

June 9, 2022

Study Completion Date

June 9, 2022

Conditions

Efficacy and Safety

Interventions

DRUG

Huazhi Rougan granule

Trial Locations (1)

Longhua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai

All Listed Sponsors

lead

Shandong New Time Pharmaceutical Co., LTD

INDUSTRY

NCT06202456 - A Phase IV Study of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver | Biotech Hunter | Biotech Hunter